to lacking of working capital and also having a lot of debts, the money from the Transaction will help the Company’s financial status better. 7. Plan of using the money After the Company receiving the

carried out as planned and expected the new buildings will be ready to be use in 3Q2021. At present, the Company is now adjusting construction drawing, system work, and also working for the environmental

create better value for the Company. Cash Flow from Investing Activities CFI as of June 30, 2019 was -23.08mb due to increased investment of surplus working capital in a mutual fund in accordance with our

investment or any other activities to create better value for the Company. Cash Flow from Investing Activities CFI as of June 30, 2019 was -23.08mb due to increased investment of surplus working capital in a

or 0.79% comparing with December 31, 2018 due to short term loan for working capital was increased by Baht 145.37 million and the Company’ s account payable was decreased by Baht 66.85 million. In

M.D. 042/2020 February 12, 2020 Subject : Disclosure of the information connected transactions To : President of the Stock of Exchange of Thailand Kang Yong Electric Public Company Limited hereby

M.D. 042/2020 February 12, 2020 Subject : Disclosure of the information connected transactions (Revised) To : President of the Stock of Exchange of Thailand Kang Yong Electric Public Company Limited

์ - 34-0135 www.interpharma.co.th Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135

working capital. Profit In 2Q18, the Company had consolidated net profit of THB 34.5mn. Net profit per share in 2Q18 was THB 0.01. Financial Position (as of 30 June 2018) Assets Total assets of the Company

1 บริษัท เจ. เอส. พ.ีพร็อพเพอร์ตี ้จ ำกดั (มหำชน) J.S.P.PROPERTY PUBLIC COMPANY LIMITED 41/1 ถ.พระรำมที ่2 ซอย 54 แขวงแสมด ำ เขตบำงขนุเทียน กรุงเทพฯ 10150 41/1 Rama 2 Soi 54 Rd., Samae-Dam, Bang Khun